EICHORCondition: Obesity · Sponsor: Yonsei University
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to establish a prospective cohort. From registration to the 5th year, basic investigation, specific examinations for cardiovascular and metabolic disease, basic blood tests, collection of human material samples, and clinical event follow-up are conducted yearly. The obese group will be examined yearly, and telephone follow-up will be conducted if necessary. The control group will participate in the baseline survey once enrollment and clinical event follow-up by phone will be conducted annually thereafter. From the 6th year, only clinical event follow-up will be conducted.
This description comes directly from the study's public registry record.
Sungha Park · +82-2-2228-8455 · shpark0530@yuhs.ac
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion criteria for the obese group 1. Adults 19 years of age or older 2. Obese patients with chronic diseases such as cardiovascular disease, hypertension, diabetes, and metabolic syndrome (BMI ≥ 25 kg/m2, \[BMI ≥ 30 kg/m2, including 10% or more\]) Inclusion criteria for the control group 1. Adults 19 years of age or older 2. Those with BMI 18.5\~24.9 kg/m2 Exclusion criteria for the obese group 1. Serious non-cardiovascular disease with life expectancy less than 6 months 2. Pregnant or suspected of being pregnant or are lactating 3. Patients within 3 months of organ transplantation 4. Patients currently being treated for acute transplant rejection 5. Patients treated for acute coronary syndrome (myocardial infarction, unstable angina) and discharged within 6 months 6. Patients with acute cerebral infarction within 6 months of being hospitalized and discharged 7. Type 1 Diabetes 8. Patients taking steroids, female hormones 9. Those who have difficulty using smartphones Exclusion criteria for the control group 1. Serious non-cardiovascular disease with life expectancy less than 6 months 2. Pregnant or suspected of being pregnant or are lactating 3. Persons who are continuously taking medications prescribed by a doctor due to chronic diseases excluding hypertension and dyslipidemia 4. Within 5 years of diagnosis of malignant tumor 5. Those who have difficulty using smartphones
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Yonsei University Health System, Severance Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05494138